About
StaniPharm is a contract development and manufacturing organization (CDMO) that develops and GMP-manufactures pharmaceutical and life-science products using supercritical CO2 technologies and nanosizing techniques. Their services include production of nanoformulations, nanosized APIs, botanical extracts, and purification/fractionation of polymers and lipids for clinical and commercial use.
Explore StaniPharm's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.